Nalena vs Precision Telemed
Two GLP-1 desks, one scoreboard. We put Nalena and Precision Telemed head-to-head on the published Brief Score — the same six factors, scored the same way.
Precision Telemed
The verdict
Precision Telemed takes this head-to-head.
Precision Telemed scores 85 to 74 on our six-factor Brief Score — A LegitScript-certified, nationwide desk with clean mid-low pricing on both molecules.
That doesn't make Nalena a bad call — it's best for readers who want women-focused glp-1-only platform with no membership or hidden fees. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Nalena | Precision Telemed | |
|---|---|---|
| Brief Score | 74/100 (C) | 85/100 (B) |
| Semaglutide | From $149/mo (starting dose, compounded) | $149/mo |
| Tirzepatide | From $149/mo (starting dose, compounded) | $199/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
Nalena: New to the tracker on 1 August 2026. The published line reads From $149/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
Precision Telemed: $149 sema / $199 tirz nationwide; LegitScript-certified.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.